Marc Cohn has taken took Instagram to reveal his hope amid his Parkinson's disease diagnosis. "I feel like it's time to tell you, my fans, what many of my colleagues, friends and family already know.

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

The U.S. will ban nearly all uses of the common industrial cleaning agent, trichloroethylene (TCE), this year—more than 50 years after it led to one of the country's worst cases of contaminated drinking water.

London, has collaborated with the London-based advocacy group Parkinson's In Motion and The Michael J. Fox Foundation (MJFF) to introduce legislation that would

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, according to a new Irish study.

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment.

Kevin Hill, 65, used to suffer sleepless nights due to his harrowing Parkinson's disease symptoms. Now, he forgets about his illness for "days and days."

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month that mold exposure in a rented apartment caused Parkinson’s disease in a former head of several Olympic sports organizations.

"There will be a cure for Parkinson's one day." Follow BBC Hereford & Worcester on BBC Sounds, Facebook, X and Instagram.

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation capable of providing sustained release of 17β-Estradiol (E2), a hormone crucial for managing neurodegenerative conditions like PD.

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve their overall well-being.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating and walking in a mid-stage study.